BEIJING, January 13, 2009 - Morgan Stanley (NYSE: MS) today announced a charitable donation and partnership with Beijing Children's Hospital (BCH), China's leading pediatrics center. The donation, which will support the hospital's new hematology and oncology center, expands Morgan Stanley's global commitment to children's health and builds on its established collaboration with leading children's hospitals in New York and London.
Morgan Stanley's grant will provide assistance to help expand the high quality medical services of Beijing Children's Hospital and enhance the standards of specialist pediatric care and treatments for children with cancer or leukemia in China. The donation will include state-of-the-art diagnostic imaging and radiotherapy equipment for the new center's Radiotherapy Center, as well as specialist training for BCH medical staff.
Dr. Li Zhongzhi, Director of BCH, said, "We are delighted with this generous contribution from Morgan Stanley, a leading financial services firm and a truly caring company. BCH and Morgan Stanley share a strong commitment to pediatric excellence and holistic care for children. This collaboration will mark an important step in the development of our Hospital and the beginning of a long-term partnership with Morgan Stanley for the benefit of children's health in China."
"We are honored to be making this contribution," said John J. Mack, Morgan Stanley's Chairman and Chief Executive Officer. "For more than 30 years, Morgan Stanley has invested in pediatric innovation so that greater numbers of children can get the healthy start in life they deserve. Our cooperation with Beijing Children's Hospital marks the first time that we are partnering with a world-class hospital in Asia on this scale, and extends our global alliance for children's health and Morgan Stanley's efforts to support centers of pediatric excellence around the world."
"We are delighted to have this opportunity to create a lasting legacy for the benefit of children by partnering with China's leading pediatric hospital," said Wei Sun Christianson, Morgan Stanley China CEO. "By contributing to BCH's new center, by training doctors and facilitating the sharing of best practices between leading pediatric centers in the US, UK and China, Morgan Stanley hopes to make a positive impact on the lives of the many children who are treated at BCH each year, and their families." BCH's new hematology and oncology center, which will have a floor area of 57,000 sqm and 360 beds, is under construction with an estimated completion date in 2011. The new center will house a dedicated Chemotherapy Center, Radiotherapy Center, Operation Center and 10 specialized wards that will boost hematology and oncology treatment capacity to a total of 400,000 children each year. The new unit will also support advanced medical procedures and greatly enhance the level of care and comfort for the young patients and their families during treatment.
Globally, Morgan Stanley has funded and helped build the Morgan Stanley Children's Hospital of New York-Presbyterian in New York City, and is partnering with Great Ormond Street Hospital in London, the UK's leading pediatric hospital, for the development of a new clinical building. Morgan Stanley is also the first major corporate supporter of Grow Clinics in the US, which are specialty operations that target families with children suffering from medical complications associated with malnourishment, primarily due to poverty.
Morgan Stanley is a leading global financial services firm providing a wide range of investment banking, securities, investment management and wealth management services. The Firm's employees serve clients worldwide including corporations, governments, institutions and individuals from more than 600 offices in 37 countries.
For further information about Morgan Stanley, please visit www.morganstanley.com.
Contact:
Beijing Children's Hospital Morgan Stanley
Xiaoju Hou (8610) 6805 0781 Li Xu (8610) 6536 2919